Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 29.46% vs 11.81% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 32.04% vs 12.71% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -22.22% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Rani Therapeutics Holdings, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 29.46% vs 11.81% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 37.80% vs 30.60% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 32.04% vs 12.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 39.13% vs 33.91% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -22.22% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -46.15% vs 0.00% in Sep 2024






